NHS shingles vaccine targeting herpes zoster virus could significantly delay onset of dementia, study suggests | Science & Tech News
A vaccine being used by the NHS to prevent shingles could also significantly delay the onset of dementia, according to new research that has left scientists baffled. The study on more than 200,000 older people shows those who were given the ‘recombinant’ vaccine Shingrix were diagnosed with dementia an average of 164 days later than those given an older-style jab. The effect was as pronounced as the first new drugs for Alzheimer’s disease, which are currently awaiting approval by UK medicines regulators. The scientists behind the study say they don’t know what the biological mechanism is for the effect, but it is highly statistically significant. “It is correlation, not causation,” said one. Previous studies have hinted the shingles vaccine may also have an effect on dementia, but this is by far the most significant research to date. The researchers seized on an opportunity for what they called a “natural experiment”. In 2017, the United States switched almost overnight from using a live vaccine called Zostavax to Shingrix, which is made using genetic techniques. Both target …